The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 15, 2019

Filed:

Aug. 22, 2017
Applicant:

Boston Scientific Neuromodulation Corporation, Valencia, CA (US);

Inventors:

Lynne E. Swanson, Edina, MN (US);

William C. Stoffregen, Lake Elmo, MN (US);

Bryan A. Clark, Forest Lake, MN (US);

Michael X. Govea, Castaic, CA (US);

Dennis B. Werner, Big Lake, MN (US);

Natalie A. Brill, Sherman Oaks, CA (US);

Pramodsingh H. Thakur, Woodbury, MN (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 1/36 (2006.01); A61B 5/00 (2006.01); A61B 1/05 (2006.01); A61F 7/00 (2006.01); A61F 7/12 (2006.01); A61N 1/05 (2006.01); A61B 5/01 (2006.01); A61B 5/0215 (2006.01); A61B 5/024 (2006.01); A61B 5/029 (2006.01); A61B 5/08 (2006.01); A61B 5/145 (2006.01); A61B 5/1473 (2006.01);
U.S. Cl.
CPC ...
A61N 1/3606 (2013.01); A61B 5/4836 (2013.01); A61B 5/686 (2013.01); A61N 1/36135 (2013.01); A61N 1/36185 (2013.01); A61B 5/01 (2013.01); A61B 5/024 (2013.01); A61B 5/029 (2013.01); A61B 5/0215 (2013.01); A61B 5/02405 (2013.01); A61B 5/0816 (2013.01); A61B 5/1473 (2013.01); A61B 5/14546 (2013.01); A61B 5/4227 (2013.01); A61B 5/4561 (2013.01); A61B 5/4809 (2013.01); A61F 7/007 (2013.01); A61F 7/12 (2013.01); A61F 2007/0075 (2013.01); A61F 2007/126 (2013.01); A61N 1/0553 (2013.01); A61N 1/0558 (2013.01); A61N 1/36007 (2013.01); A61N 1/36171 (2013.01); A61N 1/36175 (2013.01);
Abstract

Aspects of the present disclosure are directed toward apparatuses, systems, and methods for delivering therapy to an adrenal gland of a patient. The apparatuses, systems, and methods may include a lead body that attaches to a portion of the adrenal gland of the patient; and a plurality of electrodes arranged along the lead body. In addition, one or more of the plurality of electrodes may deliver stimulation energy to modulate catecholamine release from chromaffin cells within the adrenal gland.


Find Patent Forward Citations

Loading…